Publicaciones en colaboración con investigadores/as de Karolinska University Hospital (21)

2024

  1. Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

    Journal of Osteopathic Medicine

2016

  1. Infection-related and -unrelated malignancies, HIV and the aging population

    HIV Medicine, Vol. 17, Núm. 8, pp. 590-600

  2. The global spread of HIV-1 subtype B epidemic

    Infection, Genetics and Evolution, Vol. 46, pp. 169-179

2015

  1. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

    HIV Medicine, Vol. 16, Núm. 9, pp. 533-543

  2. Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

    PLoS Medicine, Vol. 12, Núm. 4

2014

  1. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

    Infection, Vol. 42, Núm. 4, pp. 757-762

2012

  1. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

    Retrovirology, Vol. 9

2011

  1. A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy

    Journal of Infectious Diseases, Vol. 204, Núm. 5, pp. 741-752

  2. European guidelines on the clinical management of HIV-1 tropism testing

    The Lancet Infectious Diseases, Vol. 11, Núm. 5, pp. 394-407

  3. European recommendations for the clinical use of HIV drug resistance testing: 2011 update

    AIDS Reviews, Vol. 13, Núm. 2, pp. 77-108

  4. Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance

    British Journal of Sports Medicine, Vol. 45, Núm. 2, pp. 147-149

2010

  1. Are elite endurance athletes genetically predisposed to lower disease risk?

    Physiological Genomics, Vol. 41, Núm. 1, pp. 82-90

  2. Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults?

    Scandinavian Journal of Medicine and Science in Sports, Vol. 20, Núm. 5, pp. 771-778

2009

  1. The C allele of the AGT Met235Thr polymorphism is associated with power sports performance

    Applied Physiology, Nutrition and Metabolism, Vol. 34, Núm. 6, pp. 1108-1111

  2. Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

    Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151

2008

  1. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

    AIDS, Vol. 22, Núm. 3, pp. 367-376

  2. Spontaneous viral clearance, viral load, and genotype distribution of Hepatitis C Virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe

    Journal of Infectious Diseases, Vol. 198, Núm. 9, pp. 1337-1344

2005

  1. Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: Increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection

    AIDS Research and Human Retroviruses, Vol. 21, Núm. 9, pp. 743-752

  2. Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: Increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection

    AIDS Research and Human Retroviruses, Vol. 21, Núm. 6, pp. 527-536

2004

  1. Updated European recommendations for the clinical use of HIV drug resistance testing

    Antiviral Therapy, Vol. 9, Núm. 6, pp. 829-848